Targeting fetal hemoglobin expression to treat β hemoglobinopathies-Reference-Cited by-同舟云学术

Targeting fetal hemoglobin expression to treat β hemoglobinopathies

Published:2022-04-03 Issue:4 Volume:26 Page:347-359
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Steinberg Martin H¹²

Affiliation:

1. Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine, Boston University School of Medicine, Boston,MA, USA

2. Department of Medicine, Division of Hematology and Medical Oncology, Center of Excellence for Sickle Cell Disease, Boston University School of Medicine, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2066519

Reference121 articles.

1. Disorders of Hemoglobin

2. Gladwin MT, Kato GJ, Novelli EM, editor. Sickle cell disease. McGraw Hill. 2021. p.692

3. Weatherall DJ, Clegg JB, eds. The thalassaemia syndromes. 4th ed. Wiley-Blackwell; 2008. p. 864.

4. Variability in the fetal hemoglobin level of the normal adult

5. TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the γ‐globin gene promoters

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction;Science;2024-07-05

2. Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease;Antioxidants & Redox Signaling;2024-01-23

3. A 6-Year Follow-up of a Chinese Child with Homozygous β ⁰ -Thalaasemia and a Heterozygous KLF1 Mutation;Hemoglobin;2024-01-02

4. Defining curative endpoints for transfusion‐dependent β‐thalassemia in the era of gene therapy and gene editing;American Journal of Hematology;2023-12-15

5. Activating transcription factor 4 in erythroid development and $$\beta $$-thalassemia: a powerful regulator with therapeutic potential;Annals of Hematology;2023-10-31